The Latest in News from the FDA/CDC

Clinical Neurology News

Cost led to missed care for 4.5% of Americans in 2017

June 28, 2018

Business of Medicine

Clinical Neurology News

Zika topped Lyme in 2016

May 10, 2018

Business of Medicine

Clinical Neurology News

Bipolar and seizure medication linked with serious immune system reaction

April 26, 2018

Epilepsy & Seizures

Clinical Neurology News

Pregnant women in clinical trials: FDA questions how to include them

April 9, 2018

Business of Medicine

Clinical Neurology News

Opioid deaths in the ED increase nationally

March 6, 2018

Pain

Clinical Neurology News

Office visits have a chronic problem

January 11, 2018

Business of Medicine

Clinical Neurology News

FDA: Gadolinium retention prompts new GBCA class warning, safety measures

December 21, 2017

Clinical Neurology News

FDA: Gadolinium retention prompts new GBCA class warning, safety measures

December 20, 2017

Clinical Neurology News

New DBS device gains approval for Parkinson’s disease

December 18, 2017

Movement Disorders

Clinical Neurology News

Developmental disabilities up significantly since 2014

December 11, 2017

Clinical Neurology News

New buprenorphine formulation approved for medication-assisted treatment

December 2, 2017

Pain

Clinical Neurology News

Public health hazard: Bring your flu to work day

November 8, 2017

Business of Medicine

Clinical Neurology News

FDA approves implantable device for central sleep apnea

October 10, 2017

Sleep Medicine

Clinical Neurology News

FDA approves biosimilar to bevacizumab

September 14, 2017

Neuro-oncology

Clinical Neurology News

Adjuvant-boosted shingles vaccine earns FDA panel’s unanimous nod

September 13, 2017

Pain